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Stroke is a major health burden in Korea as well as world-
wide. Since the population in Korea is aging fastest among the 
Organization for Economic Cooperation and Development 
(OECD) countries,1 stroke burden must substantially increase 
in the near future. Korea has achieved great economic growth 
over the past half-century, and Korea’s Gross Domestic Product 
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The aim of the Part I of Stroke Statistics in Korea is to summarize nationally representative 
data of the epidemiology and risk factors of stroke in a single document. Every year, ap-
proximately 105,000 people experience a new or recurrent stroke and more than 26,000 die 
of stroke, which indicates that every 5 minutes stroke attacks someone and every 20 min-
utes stroke kills someone in Korea. Stroke accounts for roughly 1 of every 10 deaths. The es-
timated stroke prevalence is about 795,000 in people aged ≥30 years. The nationwide total 
cost for stroke care was 3,737 billion Korean won (US$3.3 billion) in 2005. Fortunately, the 
annual stroke mortality rate decreased substantially by 28.3% during the first decade of the 
21th century (53.2/100,000 in 2010). Among OECD countries, Korea had the lowest in-hos-
pital 30-day case-fatality rate for ischemic stroke and ranked third lowest for hemorrhagic 
stroke in 2009. The proportion of ischemic stroke has steadily increased and accounted for 
76% of all strokes in 2009. According to hospital registry studies, the 90-day mortality rate 
was 3-7% for ischemic stroke and 17% for intracerebral hemorrhage. For risk factors, among 
Korean adults ≥30 years of age, one in 3-4 has hypertension, one in 10 diabetes, and one in 
7 hypercholesterolemia. One in 3 Korean adults ≥19 years of age is obese. Over the last 10 
years, the prevalence of hypertension slightly decreased, but the prevalence of diabetes, hy-
percholesterolemia, and obesity increased. Smoking prevalence in men has decreased, but is 
still as high as 48%. This report could be a valuable resource for establishing health care 
policy and guiding future research directions.
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(GDP) ranks 15th in the world in 2011. Stroke research in Ko-
rea has also achieved great advances. The annual growth of clini-
cal and epidemiological stroke articles of Korea was more than 
twice the worldwide average, and for the quantity of articles 
Korea was ranked on the 8th position worldwide, 2nd position 
after Japan among Asian countries.2 However, despite these 
achievements, a representative summary of stroke statistics in 
Korea has not been formally published. As a result, establishing 
an efficient health care plan and guiding future research direc-
tions to reduce the burden of stroke in Korea lack firm scientific 
underpinning. Accordingly, the Korean Stroke Society (http://
www.stroke.or.kr/) and the Clinical Research Center for Stroke 
(http://www.stroke-crc.or.kr/) decided to summarize nation-
ally representative data on stroke and to present them in a single 
document of Stroke Statistics in Korea. The current report fo-
cuses on stroke epidemiology and risk factors, and data of acute 
stroke management will be presented in another future report. 
For the current report, we searched the most representative na-
tional data from reports of the Korean government or related 
organizations and published articles. When representative na-
tional data are not available, we present the most relevant data 
of hospital-based studies from a literature review, recognizing 
the limitations. If there are discrepancies in data across reports, 
we adopt data of original reports rather than summary reports. 
The current report of Stroke Statistics in Korea would be a valu-
able resource for healthcare providers, researchers, policy mak-
ers, and the public who seek the best national data on stroke. 
Stroke incidence
Each year, about 105,000 Korean people experience a new or 
recurrent stroke. On average, every 5 minutes stroke attacks 
someone in Korea. The stroke incidence was adopted from the 
2006 report of the Construction of National Surveillance Sys-
tem for Cardiovascular and Cerebrovascular Diseases, which 
analyzed the 2004 in-surance claim database of the Korean 
Health Insurance Review Agency and national death certificate 
data to estimate the nationwide stroke incidence in Korea.3 In 
that study, the stroke diagnosis of the insurance claim data was 
certified from the review of individual cases for a representative 
sample, using a diagnostic algorithm combining clinical and im-
aging data. According to a nation-wide hospital-based stroke 
registry study, one in five ischemic strokes or TIAs was a recur-
rent stroke.4
The estimated incidence is 216 per 100,000 person-years. 
The age-specific stroke incidence is presented in Figure 1. With 
increasing age, the incidence per 100,000 person-years steeply 
increased from 20 in population aged ≤44 years to 3,297 in 
those aged ≥85 years. The overall incidence was greater in wo-
men (220/100,000 person-years) than in men (213/100,000 
person-years). However, when stratified by age group, the inci-
dence was greater in men than in women across all age groups 
(Figure 2). The discrepancy is attributed to more elderly popu-
lation in women than in men.3
Stroke in the population aged 65-74 accounted for more than 
30% of all strokes. When stratified by sex, the 65-74 age group 
accounted for the largest proportion in men, whereas the age 
group of 75-84 years accounted for the largest proportion in 
women (Figure 3). For ischemic stroke and unclassified stroke, 
the relative contribution of each age group was generally consis-
tent with the findings of all strokes (Figures 4 and 5). In con-
trast, the contribution of younger age groups for hemorrhagic 
stroke was greater than for ischemic stroke, and hemorrhagic 
stroke in the population under 55 years of age accounted for 
Figure 1. Age-specific stroke incidence. Source: Korean Center for Disease 
Control. Construction of National Surveillance System for Cardiovascular & 
Cerebrovascular Diseases 2006. 
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Figure 2. Sex- and age-specific stroke incidence. Source: Korean Center for 
Disease Control. Construction of National Surveillance System for Cardiovas-
cular & Cerebrovascular Diseases 2006. 
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41.2% in men and 27.3% in women of all hemorrhagic strokes 
(Figure 6). 
By 2030, the annual stroke incidence in Korea is estimated to 
rise up to 350,000 due to a rapid increase in elderly population.5 
Stroke incidence data from prospective cohort studies of repre-
sentative populations are not available in Korea, and future re-
search is needed.
Ischemic stroke and hemorrhagic stroke
According to an estimation from the database of Korean 
Health Insurance Review Agency during the period from 1995 
to 2003, the age-standardized incidence of ischemic stroke in 
the population 35-74 years of age increased annually by 7.18%, 
whereas hemorrhagic stroke decreased annually by 1.82% and 
unclassified stroke by 9.21%. As a result, the proportion of isch-
emic strokes among all strokes increased from 43% in 1995 to 
65.2% in 2003 (Figure 7).6 
For stroke admission as a primary diagnostic code (ICD-10 
code: hemorrhagic stroke for I60-62, ischemic stroke for I63) 
during 2001 to 2009, admission for hemorrhagic stroke remain-
ed stable, but admission for ischemic stroke increased substan-
tially (Figure 8). Therefore, the proportion of ischemic stroke 
admissions increased from 64.7% in 2000 to 76.1% in 2009 
(Figure 9). Among hemorrhagic stroke admissions, the ratio of 
intracerebral hemorrhage to subarachnoid hemorrhage remain-
ed stable, ranging between 2.3 and 2.6.7-10 
Ischemic stroke subtype
Data of ischemic stroke subtype from population-based stud-
ies are not available. According to a nationwide hospital-based 
stroke registry study which evaluated the Trial of ORG 10172 
in Acute Stroke Treatment (TOAST) classification11 for 36,191 
ischemic strokes between 2002 and 2010, large artery athero-
sclerosis (LAA, 36.1%) was the most common type, followed 
Figure 3. Any stroke, proportion of each age group. Source: Korean Center for 
Disease Control. Construction of National Surveillance System for Cardiovas-
cular & Cerebrovascular Diseases 2006. 
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Figure 4. Ischemic stroke, proportion of each age group. Source: Korean Cen-
ter for Disease Control. Construction of National Surveillance System for Car-
diovascular & Cerebrovascular Diseases 2006. 
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Figure 5. Unclassified stroke, proportion of each age group. Source: Korean 
Center for Disease Control. Construction of National Surveillance System for 
Cardiovascular & Cerebrovascular Diseases 2006. 
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Figure 6. Hemorrhagic stroke, proportion of each age group. Source: Korean 
Center for Disease Control. Construction of National Surveillance System for 
Cardiovascular & Cerebrovascular Diseases 2006. 
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by small vessel occlusion (SVO, 25.4%) and cardioembolism 
(CE 17.1%). Over the nine years, the relative proportion of car-
dioembolism increased, large artery atherosclerosis remained 
stable, and small vessel occlusion and stroke due to undeter-
mined etiology decreased.4 That study did not include patients 
who were admitted to non-neurology departments or who ar-
rived at the emergency department but were not hospitalized. 
However, data of the excluded patients are unlikely to substan-
tially change the study findings.
Stroke prevalence
An estimated 795,000 Koreans ≥30 years of age had a stroke 
diagnosed by physicians (extrapolation of prevalence data of 
the 2005 Korean National Health and Nutrition Examination 
Survey [KNHANES]12 to 2012 population provided by Korean 
Statistical Information Service5). The KNHANES is a cross-
sectional survey to assess the health and nutritional status of 
adults and children in Korea, using interviews and examina-
tions for a representative national sample of the Korean popula-
tion selected from a complex, stratified, multistage probability 
cluster sampling design. The age-standardized stroke prevalence 
in population ≥30 years of age is estimated to be 1.59% (data of 
KNHANES 2005). For each sex, roughly 411,000 Korean men 
(1.64%) and 384,000 (1.54%) Korean women have had a stroke. 
Stroke prevalence steeply increases with age. The 2005 
KNHANES data demonstrated that the prevalence increased 
from 0.14% in the 30-39 years old population to 6.75% in those 
≥70 years of age (Figure 10).12 Another study also showed that 
the estimated stroke prevalence increased from 0.15% for men 
and 0.09% for women in the population aged ≤45 years to 7.21% 
for men and 4.98% for women ≥85 years of age (Figure 11).3 
According to the 2010 KNHANES data, the prevalence of stroke 
diagnosed by physicians was 2.9% (3.7% for men, 2.3% for wo-
men) for the population ≥50 years of age and 4.5% (5.6% for 
men, 3.7% for women) for those ≥65 years. However, there is a 
substantial variation in the prevalence data between 1998 and 
2010, suggesting limitations of the survey studies in the accura-
cy of diagnostic criteria (Figure 12).13 
The KNHANES 2010 report showed that the lower income 
population had a higher stroke prevalence than high income 
population in both men and women during 1998-2010 (Figure 
13). The difference in stroke prevalence between low income 
and high income populations was generally greater in men than 
in women (Figures 14 and 15).13
Stroke mortality 
In 2010, stroke killed 26,517 Korean people. Stroke is the 
Figure 7. Age- and sex-standardized stroke incidence in population with 35-74 
years. Source: Korean Center for Disease Control. Development of Strategy and 
Action Plans for Major Chronic Diseases Prevention and Control 2004. 
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second leading cause of death after cancer and the first leading 
cause of death due to a single organ disease. Stroke death ac-
counted for approximately one of every 10 deaths in Korea. On 
the average, every 20 minutes stroke kills someone. The annual 
Figure 10. Stroke prevalence by age. Source: KNHANES 2005. 
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Figure 11. Stroke prevalence by age and sex. Source: Korean Center for Dis-
ease Control. Construction of National Surveillance System for Cardiovascular 
& Cerebrovascular Diseases 2006. 
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Figure 12. Stroke prevalence by year. Source: KNHANES 2010.
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Figure 13. Stroke prevalence by income. Source: KNHANES 2010.
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Figure 14. Stroke prevalence by income, men. Source: KNHANES 2010.
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Figure 15. Stroke prevalence by income, women. Source: KNHANES 2010.
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stroke mortality rate in 2010 was 53.2 per 100,000 (51.5/100,000 
for men and 54.8/100,000 for women) (Figure 16).14-16 More 
women than men die of stroke. 
From 2001 to 2010, the age-standardized stroke death rate 
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decreased by 28.3% (27.9% for men and 28.9% for women) 
(Figure 16), and the actual number of stroke deaths declined by 
25.4% (Figure 17). During that period, the contribution of 
stroke deaths to all deaths decreased from 14.7% to 10.4% (from 
12.8 % to 9.0% for men and from 17.1% to 12.1% for women) 
(Figure 18).14-16 Over the 10 years, women had a higher stroke 
mortality rate than men, and there was no substantial change in 
women-to-men ratio (from 1.08 to 1.06).14-16
Stroke mortality rates steeply increased with age, particularly 
after age 70. Compared to the population 60-69 years of age, 
stroke mortality rate increased by 4-fold in those 70-79 years of 
age and by 13-fold in those ≥80 years of age (Figure 19).14
In Korea, age-standardized stroke mortality rate has a geo-
graphic disparity (range, 27.5/100,000 to 47.8/100,000). In 
2010, Jeollabuk-do, the southwest province (47.8/100,000), 
and Gangwon-do, the northeast province (47.4/100,000) rank-
Figure 16. Trend of crude stroke mortality rate. Source: Korean Statistical In-
formation Service (KOSIS). Annual Report on the Cause of Death Statistics, 
Korean Center for Disease Control. Health Behavior and Chronic Disease Sta-
tistics 2005.
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Figure 17. Trend of actual number of stroke deaths. Source: Korean Statistical 
Information Service (KOSIS). Annual Report on the Cause of Death Statistics, 
Korean Center for Disease Control. Health Behavior and Chronic Disease Sta-
tistics 2005. 
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Figure 19. Age-specific stroke mortality rate (2010). Source: Korean Statistical 
Information Service (KOSIS). Annual Report on the Cause of Death Statistics. 
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ed No. 1 and No. 2, and Jeju island had the lowest stroke mor-
tality rate (27.5/100,000) followed by Seoul (34.8/100,000) 
(Figure 20).14 The average age-standardized mortality rate did 
not differ between metropoiltan cities and the other regions 
(42.5/100,000 vs 42.4/100,000).
30-day case-fatality rate of stroke
Stroke 30-day case-fatality rate usually indicates the propor-
tion of deaths within 30 days after the index stroke. The Korean 
Center for Disease Control reported that the 30-day case-fatali-
ty rate was 23.9% (95% confidence interval, 22.2-25.8%) in 
2004.3 Compared to ischemic stroke, hemorrhagic stroke caused 
a 2.4-fold higher case-fatality rate (35.0% vs. 15.2%). Women 
had a higher case-fatality rate for any stroke and ischemic stroke 
than men, whereas the hemorrhagic stroke case-fatality rate was 
slightly higher in men than in women (Figure 21). For any stroke 
Figure 21. 30-day case-fatality rate. Source: Korean Center for Disease Con-
trol. Construction of National Surveillance System for Cardiovascular & Cere-
brovascular Diseases 2006. 
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Figure 22. 30-day case-fatality rate of stroke by age. Source: Korean Center 
for Disease Control. Construction of National Surveillance System for Cardio-
vascular & Cerebrovascular Diseases 2006. 
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Figure 23. 30-day case-fatality rate of ischemic stroke by age. Source: Korean 
Center for Disease Control. Construction of National Surveillance System for 
Cardiovascular & Cerebrovascular Diseases 2006. 
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Figure 24. 30-day case-fatality rate of hemorrhagic stroke by age. Source: Ko-
rean Center for Disease Control. Construction of National Surveillance System 
for Cardiovascular & Cerebrovascular Diseases 2006. 
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and ischemic stroke, with increasing age, the 30-day case-fatality 
rate generally increased in both men and women (Figures 22 
and 23). However, the case-fatality rate for hemorrhagic stroke 
showed a complex pattern of a relatively high 30-day case-fatali-
ty rate in younger age groups (Figure 24).
In contrast, the Korean Stroke Registry Study in which 31 
centers nationwide prospectively enrolled 46,098 patients with 
ischemic stroke from 2002 to 2010 showed that the average 30-
day case-fatality rate of ischemic stroke was 4%. During the pe-
riod, the age-adjusted 30-day case fatality rate did not decline, 
but the age-adjusted 1-year mortality rate did decline signifi-
cantly.4 The discrepancy in the 30-day case-fatality rate across 
the studies might attribute to differences in population, meth-
od, and time period, and further studies are needed to assess 
the current trend of 30-day stroke case-fatality rate. 
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In-hospital mortality rate
Acute stroke treatment has advanced dramatically over the 
last decade, and quality of stroke care in Korean hospitals has 
substantially improved. The Health Care Quality Indicators 
Project data demonstrated that, among OECD countries, Ko-
rea had the lowest in-hospital 30-day case-fatality rate for isch-
emic stroke (crude rate, 2.5%; age-sex standardized rate, 1.8%) 
and ranked third lowest for hemorrhagic stroke (crude rate, 
10.2%; age-sex standardized rate, 9.8%) in 2009 (Figures 25 
and 26).17 Although the analysis did not adjust for stroke severi-
ty, the single most important determinant of outcome, these 
findings suggest that hospitals in Korea are providing a high 
quality of acute stroke care.
According to the Report of Assessment for Quality of Acute 
Stroke Care in Korea 2010, the crude in-hospital mortality rate of 
acute stroke admission was 8.3% for any strokes, 4.3% for ische-
mic strokes, and 17.5% for hemorrhagic stroke. The crude mortal-
ity rates were stable during the period of 2005-2010 (Figure 27).9 
90-day functional outcome after stroke
Since stroke disables as well as kills people, disability after 
stroke is an important burden to patients, their family, and soci-
ety. Therefore, measuring burden of stroke should incorporate 
the post-stroke disability as well as mortality. Since more than 
90% of stroke recovery occurs in the first 3 months in most 
stroke patients,18 residual post-stroke disability is usually as-
sessed at 90 days after stroke. For a disability outcome measure, 
modified Rankin Scale (mRS) is most widely favored and rec-
ommended by researchers and regulatory authorities.19, 20 
For a nationwide representative population cohort, fine-grain-
ed 90-day mRS disability after stroke has not been evaluated in 
Korea as well as in most other countries, but several hospital-
based registry studies have reported 90-day mRS disability out-
come. For ischemic stroke, 49-66% of patients had an excellent 
outcome of mRS 0-1 and 63-80% had a good outcome of mRS 
0-2. Mortality rates at 90 days ranged 3-7% across the studies.21-23
For hemorrhagic stroke, a single center study reported 3-month 
mRS outcome for 585 primary intracerebral hemorrhage.24 As 
expected, hemorrhagic strokes had worse 90-day outcomes than 
ischemic strokes. Twenty-nine % of patients achieved indepen-
dent outcome of mRS 0-3, and 16.9% were dead at 90 days.
Disability-adjusted life years (DALY) lost 
due to stroke
The DALY is a formal metric of the World Health Organiza-
tion Global Burden of Disease Project (WHO-GBDP) to mea-
sure regional and global burdens of hundreds of diseases. The 
DALY incorporates disability and mortality into a single metric 
of healthy life years lost, whereby one DALY lost indicates one 
Figure 25. In-hospital case-fatality rate within 30 days after admission of isch-
emic stroke. Source: OECD (2011), Health at a Glance 2011: OECD Indicators, 
OECD Publishing. (http://dx.doi.org/10.1787/health_glance-2011-en).
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Figure 26. In-hospital case-fatality rate within 30 days after admission of he-
morrhagic stroke. Source: OECD (2011), Health at a Glance 2011: OECD Indica-
tors, OECD Publishing. (http://dx.doi.org/10.1787/health_glance-2011-en).
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Figure 27. Crude in-hospital mortality rates for acute stroke admission. Source: 
Korean Health Insurance Review & Assessment Service. Report of Assessment 
for Quality of Acute Stroke Care in Korea 2010.
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year loss of healthy life, free of disability.25
In high income countries, the DALY lost to ischemic heart 
disease is usually greater than the DALY lost to stroke. Howev-
er, among high income countries, Korea ranked No. 1 of greater 
DALY lost to stroke than to ischemic heart disease.26 In the 
WHO-GBDP report, Korea is categorized into a group wherein 
the DALY lost to stroke is between 641 and 880 per 100,000 
person-years. More specifically, the sex- and age-adjusted DALY 
lost per 100,000-years was 703, and the unadjusted DALY lost 
was 855 (obtained from a personal communication with S. Clai-
borne Johnston, who is the first author of a related article27). 
Therefore, nationwide annual DALY lost to stroke would be 
about 344,000.
For ischemic stroke, the projected nationwide DALY lost due 
to 64,688 ischemic strokes in 2004 was 234,399 (121,482 for 
men and 113,244 for women), and the DALY lost per 100,000 
person-years was 483 (500 for men and 469 for women). The 
DALY lost of 65-74 years contributed 37.9% to overall DALY 
lost, followed by the age groups of 75-84 and 55-64 years.28
Economic cost of stroke
According to estimates from the Korean National Health In-
surance Claims Database for 2005, the nationwide total cost for 
stroke was 3,737 billion Korean won (KRW) (US$3.3 billion) 
which included direct costs of 1,130 billion KRW (US$1.0 bil-
lion) and indirect costs of 2,606 billion KRW (US$2.3 billion).29 
In 2009, the total cost for admission and out-patient clinic for 
stroke care paid by the Korean Health Insurance Agency was 
870.3 billion KRW (545.2 billion KRW for ischemic stroke and 
325.1 billion KRW for hemorrhagic stroke), which increased by 
54.7% from 2005 (Figure 28).9 
For each stroke admission, the average costs in 2009 were 
4.92 million KRW for any stroke, 3.95 million KRW for isch-
emic stroke, and 7.82 million KRW for hemorrhagic stroke, 
which gradually increased during the period of 2005-2009 (Fig-
ure 29). Compared with an ischemic stroke admission, a hem-
orrhagic stroke admission carries a 2-fold greater cost.7-9 
The average lifetime cost for men who had a first stroke was 
estimated to be 200.7 million KRW at age 45, 81.9 million KRW 
at age 55, and 16.4 million KRW at age 65. For women, it was 
estimated to be 75.7 million KRW at age 45, 39.2 million KRW 
at age 55, and 19.3 million KRW at age 65. While strokes in those 
45-64 years of age accounted for only 30% of all strokes, this age 
group incurred 75% of the total national lifetime costs of stroke.30 
However, the study might underestimate the lifetime cost since 
it did not consider the productivity loss of housewives and loss 
due to disability. 
Risk factors
Hypertension
Hypertension (HT) is the most important well-documented 
and modifiable risk factor for stroke. For blood pressure over 
115/75 mm Hg, an increase in systolic blood pressure (SBP) of 
20 mmHg or in diastolic blood pressure (DBP) of 10 mmHg 
was associated with a more than 2-fold increased risk of stroke 
mortality.31 In a meta-analysis of clinical trials, antihypertensive 
treatment reduced the risk of stroke by 32% (95% CI, 24-36%).32 
Prevalence
HT is defined as SBP≥140 mm Hg or DBP≥90 mm Hg or 
Figure 28. Total cost for admission and out-patient clinic paid by Korean Health 
Insurance Agency. Source: Korean Health Insurance Review & Assessment 
Service. Report of Assessment for Quality of Acute Stroke Care in Korea 2005-
2010. 
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Figure 29. Average admission cost for stroke care. Source: Korean Health In-
surance Review & Assessment Service. Report of Assessment for Quality of 
Acute Stroke Care in Korea 2005-2010. 
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taking antihypertensive medicine. 
One in 3-4 Korean adults ≥30 years of age has HT, and ap-
proximately 7,500,000 adults ≥30 years of age have HT (data 
from 2010 KNHANES adjusted to 2005 standardized popula-
tion).13 The age-adjusted prevalence of HT decreased during 
1998 to 2007, but slightly increased from 2007 to 2008, and 
then remained stable since 2008 (Figure 30).13
Data from NHANES 2010 showed that 28.9% of people aged 
≥30 years had HT. HT was more prevalent in men than in wo-
men in those ≥30 years of age (30.1% vs. 27.7%). Until 59 years 
of age, a higher percentage of men than women have HT, but 
from 60 years of age HT was more prevalent in women than in 
men (Figure 31).13 In the population <50 years of age, men 
had twice the prevalence of HT than women. 
Data from NHANES 2010 showed that the prevalence of HT 
in men increased until 60-69 years and then slightly decreas ed, 
and the HT prevalence in women monotonically increased with 
age. In men of 30-59 years, the prevalence of HT almost dou-
bled with every 10-year increase of age. In women 30-69 years 
of age, the HT prevalence increased by nearly 10-fold from 30-
39 years to 40-49 years, by almost 3-fold from 40-49 years to 
50-59 years, and by a 1.7-fold from 50-59 years to 60-69 years 
(Figure 31). Compared to worldwide prevalence data,33 the HT 
prevalence in Korea is lower in men 30-49 years old and ≥70 
years and in women aged 30-59 years and ≥70 years, but higher 
in men 50-69 years old and in women of 60-69 years.
Blood pressure
Data from KNHANES 2010 showed that with increasing 
age, SBP increased monotonically, and DBP increased until 60 
years and then decreased in both men and women. For people 
of age less than 60 years, men had a higher SBP than women, 
but from age 60 SBP was higher in women than in men. DBP 
had a similar trend (Figure 32).13
Awareness, treatment, and control 
Data from KNHANES 2008-2010 showed that among peo-
ple aged ≥30 years with hypertension, 67.9% were aware of 
their HT (diagnosed by physicians), 61.9% were on regular 
treatment (taking medication ≥20 days per month), and 43.6% 
had their blood pressure under control (SBP <140 mmHg and 
DBP was <90 mmHg).13 The awareness, treatment, and con-
trol of HT improved compared to data of KNHANES 2007-
2009 (Figure 33),34 but still remained less than those of the US 
population.35 
Women had higher percentages of awareness, treatment, and 
control of HT than men for all age groups. Younger age groups 
showed lower percentages of awareness, treatment, and control 
of HT than elderly groups. In people 30-39 years of age, less 
than 30% were aware of their HT, less than 20% had regular 
treatment, and about one of ten had their blood pressure under 
control (Figure 34). Figure 30. Trends of age-standardized prevalence of HT. Source: KNHANES 
2010.
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Figure 31. HT prevalence by age (2010). Source: KNHANES 2010.
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Figure 32. Blood pressure by age (2010). Source: KNHANES 2010.
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Smoking
Prevalence in adults
From 1998 to 2007, the age-standardized prevalence of cur-
rent smoking in Korean men ≥19 years of age declined from 
66.3% to 45.3%, but increased slightly from 2007 to 2010 (48.3%). 
For women, smoking prevalence remained low (ranging 5.2-
7.4%) (Figure 35).13 The smoking prevalence from KNHANES 
2010 data (48.1% in men and 6.1% in women) was substantial-
ly higher in men and substantially lower in women compared to 
the US population (21.2% in US men and 17.5% in US wom-
en).35 Data from KNHANES 2010 showed that the smoking 
prevalence in men was highest in 30-39 years of age (60.9%) 
and then decreased with age. However, more than half of men 
19-59 years of age were still smoking (Figure 36).13 
Secondhand smoke
Secondhand smoke also increases the risk of stroke. In KN-
HANES 2010, secondhand smoke was defined as inhalation of 
smoke in home or office by persons other than intended active 
smokers. From 2005 to 2010, the percentage of secondhand 
smoke slightly increased from 36.4% to 39.7%.13 
Diabetes mellitus
People with diabetes mellitus (DM) have an increased risk of 
stroke. In patients with type 2 diabetes, each 1% increase in Hb-
A1c was associated with a 12% increase of relative risk of stroke.36 
Prevalence
In KNHANES 2010, DM was defined as fasting glucose ≥126 
mg/d, diagnosis by physicians, or being treated with oral hypo-
glycemic agents or insulin. 
One in ten Korean adults ≥30 years of age have DM, and 
Figure 33. Trends of awareness, treatment, and control of HT. Source: KNHA-
NES 2010.
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Figure 34. Awareness, treatment, control of HT by age and sex (2008-2010). 
Source: KNHANES 2010.
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Figure 35. Trends of age-standardized prevalence of smoking. Source: KNHA-
NES 2010.
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Figure 36. Smoking prevalence by age (2010). Source: KNHANES 2010.
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around 2,730,000 adults have DM (data from 2010 KNHANES 
adjusted to 2005 standardized population).13 The age-standard-
ized prevalence of DM increased from 8.6% in 2001 to 9.7% in 
2010, and the increase was greater in men (from 9.5% in 2001 
to 11.0% in 2010) than in women (from 7.9% in 2001 to 8.3% 
in 2010) (Figure 37).13
Data from KNHANES 2010 showed that 10.1% of popula-
tion ≥30 years of age had DM. DM was more prevalent in men 
than in women (11.3% vs. 9.0%). Except for those 60-69 years 
of age, the prevalence of DM was higher in men than in women 
(Figure 38).13 Notably, in those 50-59 years of age, men had 
twice the prevalence of DM than women. 
Data from KNHANES 2010 showed that the prevalence of 
DM in men increased until age 59, then slightly decreased in 
those aged 60-69 years, and then increased again after age 70. In 
contrast, in women, the prevalence of DM monotonically in-
creased with aging. The steepest increase of DM prevalence was 
observed in 50-59 years for men and 60-69 years for women.
Blood glucose
According to data from KNHANES 2010, blood glucose lev-
el generally increased with aging. In women, as age increased, 
blood glucose level increased monotonically whereas in men 
blood glucose level increased until 50-59 years of age and then 
decreased after 60 years. In those less than 70 years old, men 
had a higher blood glucose level than women, but from age 70 
blood glucose level was higher in women than in men (Figure 
39).
Awareness, treatment, and control 
Data from KNHANES 2008-2010 showed that of people 
with DM ≥30 years old, 73.0% were aware of their DM (diag-
nosed by physicians), 59.1% were on regular treatment (treat-
ment with oral hypoglycemic agents or insulin), and 28.1% had 
their DM under control (HbA1c<6.5%).13 The awareness, treat-
ment, and control of DM were comparable to data of KN HA-
NES 2007-2009 (Figure 40).34
Data from KNHANES 2010 showed that the percentages of 
awareness and treatment were higher in women than in men 
(awareness, 77.6% vs. 69.0%; treatment, 64.0% vs. 54.9%), but 
the percentage of control was higher in men than in women 
(30.1% vs. 25.8%). In men, younger age groups, particularly 
those 30-39 years of age, showed substantially low percentages 
of awareness, treatment, and control. In women, the percentage 
of awareness was generally high for all age groups. However, in 
young women, the percentages of treatment and control were 
very low given their high percentage of awareness (Figure 41).
Dyslipidemia
Despite the inconsistent epidemiological findings of the asso-
ciation between hypercholesterolemia and stroke, lowering 
cholesterol with statins reduces the risk of ischemic stroke in 
patients with high risk for stroke or with non-cardioembolic 
Figure 37. Trends of age-standardized prevalence of DM. Source: KNHANES 
2010.
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Figure 38. DM prevalence by age (2010). Source: KNHANES 2010.
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Figure 39. Blood glucose by age (2010). Source: KNHANES 2010.
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stroke. Each 1 mmol/L (39 mg/dL) decrease of LDL-choles-
terol with statin treatment reduced the relative risk of stroke by 
21.1%.37 
Prevalence
In KNHANES 2010, hypercholesterolemia was defined as 
total cholesterol ≥240 mg/dL or taking cholesterol lowering 
medication, low HDL-cholesterol as <40 mg/dL, and hyper-
triglyceridemia as ≥200 mg/dL. 
Among Korean adults ≥30 years of age, one in seven has hy-
percholesterolemia, one in four has low HDL-cholesterol, and 
one in six has hypertriglyceridemia. Approximately 3,800,000 
adults ≥30 years of age have hypercholesterolemia, about 
7,400,000 have low-HDL, and 4,700,000 have hypertriglyceri-
demia (data from 2010 KNHANES adjusted to 2005 standard-
ized population).13 The age-standardized prevalence of hyper-
cholesterolemia increased from 10.0% in 1998 to 13.5% in 
2010, and the increase was greater in men (from 8.7% in 1998 
to 13.0% in 2010) than in women (from 10.6% in 1998 to 
13.4% in 2010). The age-standardized prevalence of hypertri-
glyceridemia increased during 1998 to 2001 and then remained 
stable since 2005, whereas that of low HDL-cholesterol did not 
change substantially since 2008 (Figure 42).13
Data from KNHANES 2010 showed that 14.1% of popula-
tion with ≥30 years of age had hypercholesterolemia. Hyper-
cholesterolemia was more prevalent in women than in men 
(14.9% vs. 13.4%). Until 49 years of age, the prevalence was 
higher in men than in women, but from 50 years hypercholes-
terolemia was more prevalent in women than in men (Figure 
43).13 In the population ≥60 years of age, the prevalence of hy-
percholesterolemia in women was more than two times higher 
than in men. Low HDL-cholesterol less than 40 mg/dL was 
observed in 26.5% of population ≥30 years of age, and it was 
Figure 40. Trends of awareness, treatment, and control of DM. Source: KNH-
ANES 2010.
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Figure 41. Awareness, treatment, control of DM by age and sex (2008-2010) 
Source: KNHANES 2010.
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Figure 42. Trends of age-standardized prevalence of dyslipidemia. Source: 
KN HANES 2010.
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Figure 43. Hypercholesterolemia prevalence by age and sex (2010). Source: 
KNHANES 2010.
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Figure 44. Low HDL-cholesterol prevalence by age and sex (2010).Source: 
KNHANES 2010.
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Figure 45. Hypertriglyceridemia prevalence by age and sex (2010). Source: 
KNHANES 2010.
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more prevalent in men than in women for all age groups (35.8% 
vs. 17.4%) (Figure 44). The prevalence of hypertriglyceridemia 
(≥200 mg/dL) was higher in men than in women, and in all 
age groups except for people aged ≥70 years, hypertriglyceride-
mia was more prevalent in men than in women (Figure 45).13 
Serum levels of total cholesterol, HDL-cholesterol, and 
triglyceride 
According to data from KNHANES 2010, total cholesterol 
level was highest in the 40-49 age group for men and 50-59 years 
for women. For people 19-49 years of age, total cholesterol level 
was higher in men than in women, but from age 50 it was higher 
in women than in men (Figure 46). HDL-cholesterol level was 
higher in women than in men for all age groups, and triglyceride 
level was higher in men than in women for all age groups except 
for the aged ≥70 years (Figure 47). 
Awareness, treatment, and control of hypercholesterolemia
Data from KNHANES 2008-2010 showed that among peo-
Figure 46. Source: Total cholesterol by age and sex (2010). KNHANES 2010.
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Figure 47. HDL-cholesterol and triglyceride by age and sex (2010). Source: 
KNHANES 2010.
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ple aged ≥30 years with hypercholesterolemia, 45.4% were 
aware of their hypercholesterolemia (diagnosed by physicians), 
34.7% were on regular treatment (taking medication ≥20 days 
per month), and 25.9% had their cholesterol level under control 
(total cholesterol level <200 mg/dL).13 The awareness, treat-
ment, and control of hypercholesterolemia improved compared 
to data of KNHANES 2007-2009, and the magnitudes of im-
provement were greater in women than in men(Figure 48).34 
Overall, women had higher percentages of awareness, treat-
ment, and control of hypercholesterolemia than men. Younger 
age groups had lower percentages of awareness, treatment, and 
control of hypercholesterolemia than elderly groups. Among 
people 30-39 years of age, <20% were aware of their hypercho-
lesterolemia, <10% had regular treatment, and <3% had their 
cholesterol level under control (Figure 49). 
Atrial fibrillation
There has been no representative population-based study for 
incidence and prevalence of atrial fibrillation in Korea. Howev-
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Figure 49. Awareness, treatment, control of hypercholesterolemia by age and 
sex. Source: KNHANES 2010.
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Figure 48. Trends of awareness, treatment, and control of hypercholesterol-
emia. Source: KNHANES 2010.
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er, one study reported the prevalence of atrial fibrillation in 
14,540 adults (6,573 men and 7967 women who were ≥40 
year-old inhabitants in 5 cities and 3 counties in Gyeongsang-
nam-do) who underwent general health screening test includ-
ing electrocardiography between April 2000 and December 
2000. The prevalence of AF in people ≥40 years of age was 
0.7% (1.2% in men and 0.4% in women). The AF prevalence 
was higher in men than in women for all age groups and gener-
ally increased with aging: 40-49 years of age, 0.1% (0.1% in 
men; 0.1% in women); 50-59 years, 0.5% (0.7% in men; 0.4% 
in women); 60-69 year, 1.4% (2.5% in men; 0.5% in women); 
70-79 years, 1.8% (2.7% in men; 1.0% in women); and ≥80 
years, 4.0% (4.5% in men; 3.5% in women).38 Accordingly, an 
estimated 138,000 Korean people ≥40 years of age have atrial 
fibrillation (estimated from the 2005 standardized population). 
Since elderly population ≥65 years of age is estimated to in-
crease by 5.8-fold in 2050,5 the projected AF prevalence in 2050 
would be more than 800,000 in Korea. The prevalence of 4.0% 
in Korean people aged ≥80 years was substantially lower than 
that of 10% in US population of the same age.39 Since only 1.2% 
(n=175) of all examined populations were ≥80 years,38 a well-
designed study that includes more elderly patients is required. 
Obesity 
Obesity increases blood pressure, blood glucose, blood cho-
lesterol, and the risk of stroke. 
Prevalence
Obesity in this report is defined as body mass index (BMI) 
≥25. 
One in 3 Korean adults aged ≥19 years is obese, an estimated 
8,800,000 adults (data from 2010 KNHANES adjusted to 2005 
standardized population).13 During the period of 1998-2010, 
the age-standardized prevalence of obesity substantially increas-
ed in men from 21.1% to 36.3%, but slightly decreased in wom-
en from 26.2% to 24.8% (Figure 50).13 
Data from KNHANES 2010 showed that 31.4% of popula-
tion ≥19 years of age were obese. Obesity was more prevalent 
in men than in women (36.5% vs. 26.4%). Until 59 years of age, 
the prevalence of obesity was higher in men than in women, but 
from 60 years of age, obesity was more prevalent in women than 
in men (Figure 51).13 In those less than 40 years of age, the pre-
valence of obesity in men was more than twice than in women. 
Data from KNHANES 2010 showed that the peak prevalence 
of obesity differed between men and women. For women, the 
prevalence increased until 60-69 years of age, and then decreas-
ed. For men, the prevalence was highest in 30-39 years of age, 
and then generally decreased after 40 years (Figure 51). 
According to data from KNHANES 2010, similar to obesity 
prevalence, BMI increased until 60-69 years of age in women 
and then decreased. For men, the BMI was greatest in 30-39 
years and then decreased after 40 years (Figure 52).
Recommended physical activity 
In this report, the recommended physical activity indicates a 
vigorous intensity of physical activity for ≥10 minutes at a time, 
≥20 minutes per day, and ≥3 days per week, or a moderate in-
tensity of physical activity or walk for ≥10 minutes at a time, 
≥30 minutes per day, and ≥5 days per week.
Data from KNHANES 2010 showed that only 50% of popu-
lation ≥19 years of age engaged in the recommended physical 
activity. The proportion of population who met the recommen-
dation generally decreased during the period of 2005-2010 from 
68.5% to 50.8% (Figure 53). For all age groups except for 40-49 
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Figure 51. Obesity (BMI≥25) prevalence by age and sex (2010). Source: KNH-
ANES 2010.
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Figure 54. Recommended physical activity by age and sex (2010). Source: KN-
HANES 2010.
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Figure 52. BMI by age and sex (2010). Source: KNHANES 2010.
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Figure 53. Trends of age-standardized recommended physical activity. Source: 
KNHANES 2010.
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Proportions of risk factors in patients with ischemic 
stroke or TIA in Korea
According to a nation-wide hospital-based stroke registry en-
rolling 46,098 patients with ischemic stroke or TIA between 
2002 and 2010, HT was the most common risk factor (63.5%) 
followed by smoking (33.0%), DM (30.1%), prior stroke (19.7%), 
potential sources of cardioembolism (19.4%), and dyslipidemia 
(19.3%).4 
Over the nine years, the average age increased from 64.5 years 
to 66.7 years. The proportions of HT, DM, smoking, and prior 
stroke slightly but significantly decreased (for all, p for trends 
<0.001), whereas the proportion of potential source of cardio-
embolism did not change. Trend of dyslipidemia proportions 
showed a complex pattern of non-directional fluctuation be-
tween 2002-2007, a decline between 2007-2008, and then an 
increase since 2008.
Figure 50. Trends of age-standardized prevalence of obesity (BMI≥25). Source: 
KNHANES 2010.
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years of age, the proportions of people who met the recommend-
ed physical activity were greater in men than in women. Among 
women ≥70 year of age, less than 40% met the recommenda-
tion (Figure 54).13 
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Figure 55. PAR for ischemic stroke by sex. Source: Park et al.42 with permis-
sion of the publisher.
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Population attributable risk of major stroke risk 
factors in Korea
The relative risk (RR) is the risk of developing a disease asso-
ciated with exposure to a risk factor. The RR indicates the streng-
th of association between risk factor and disease, but it could 
not delineate the disease burden of the population due to the 
risk factor. Therefore, the population attributable risk (PAR) is 
usually employed for a population-based approach such as plan-
ning public health interventions. The PAR indicates the number 
(or proportion) of diseases (for example, strokes) that would be 
averted if a risk factor (for example, hypertension) is eliminated 
from a population. The PAR in a population depends on the 
prevalence of the risk factor and the strength of its association 
(relative risk) with the disease. For example, the RR of stroke is 
greater with atrial fibrillation than with smoking. However, since 
smoking prevalence is much greater than atrial fibrillation prev-
alence, the PAR of smoking is greater than that of atrial fibrilla-
tion. 
To estimate the current PARs of individual risk factors in a 
population, contemporary population-specific prevalence and 
RR for each risk factor should be determined. In Korea, KNH-
ANES has regularly estimated the prevalence of major cardio-
vascular risk factors, but cohort studies estimating RR of each 
risk factor for stroke have been very limited. 
According to a prospective cohort study performed in 1990s 
and early 2000s, among major risk factors, hypertension had 
the highest PARs for stroke in men (35%) and women (24.7%), 
which were greater than those for ischemic heart disease (21% 
for men and 16.2% for women). The PAR of smoking for stroke 
was high for men (26%), but low (3.3%) for women. Diabetes 
and hypercholesterolemia had relatively low PARs in men (2.8% 
for diabetes and 2.6% for hypercholesterolemia).40,41
In another systematic review which employed prevalence 
data of 2005 KNHANES and RR from data of Korean or other 
population, the PARs for ischemic stroke in men were 19.9-
30.5% for hypertension, 26.5% for smoking, 6.6-23.5% for obe-
sity, 2.8-7.2% for diabetes, 2.8-4.0% for hypercholesterolemia, 
and 3.5% for atrial fibrillation. In women, the PAR was 17.1-
26.6% for hypertension, 4.1-7.2% for diabetes, 5.4% for obesity, 
3.3-4.7% for hypercholesterolemia, 3.2% for smoking, and 2.8% 
for atrial fibrillation.42 In the population 50-89 years of age, with 
increasing age, the PARs of hypertension decreased (from 56.2% 
for men and 53.4% for women to 14.5% for men and 20.9% for 
women), whereas those of atrial fibrillation increased (from 
2.2% for men and 2.3% for women to 12.8% for men and 17.0% 
for women) (Figure 55).
Summary
Stroke remains a great health burden in Korea. Risk factors 
for stroke are highly prevalent. Awareness, treatment, and con-
trol of risk factors have generally improved, but still have much 
room for improvement. Characteristics of stroke and risk fac-
tors are changing and healthcare providers need to cope with 
the changes. The current report of Stroke Statistics in Korea 
could be a valuable resource for clinicians, researchers, health-
care policy makers, and lay public who seek the best national 
data on stroke to establish a healthcare plan and to guide future 
research directions. The writing group will continuously moni-
tor and evaluate data on stroke to update the Stroke Statistics in 
Korea.
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